Position in DHR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$35,172,696
+$3,924,659 QoQ
Shares Held
185,510
+35.9% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
8.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Derivatives in DHR
reported options exposure · as of Mar 31, 2026CallValue
$7,584,000
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arvin Capital Management LP holds $60,838,789 across 3 Diagnostics & Research names.
All Filings in DHR
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,584,000 | 40,000 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $35,172,696 | 185,510 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $31,248,037 | 136,502 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $8,470,040 | 37,000 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $19,231,220 | 97,000 | Call | Sole | 2025-11-12 | |
| 2025-09-30 | $28,926,134 | 145,900 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,950,800 | 20,000 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $29,204,906 | 147,843 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,225,000 | 45,000 | Call | Sole | 2025-05-13 | |
| 2025-03-31 | $12,849,605 | 62,681 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,641,329 | 42,001 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,665,883 | 31,170 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||